An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

April 1, 2013

Primary Completion Date

December 21, 2017

Study Completion Date

December 21, 2017

Conditions
Bipolar Disorder
Interventions
DRUG

Asenapine

Asenapine prescribed as recorded in the CPRD in the UK

DRUG

Aripiprazole

Aripiprazole prescribed as recorded in the CPRD in the UK

DRUG

Quetiapine

Quetiapine prescribed as recorded in the CPRD in the UK

DRUG

Risperidone

Risperidone prescribed as recorded in the CPRD in the UK

DRUG

Olanzapine

Olanzapine prescribed as recorded in the CPRD in the UK

DRUG

Ziprasidone

Ziprasidone prescribed as recorded in the CPRD in the UK

DRUG

Iloperidone

Iloperidone prescribed as recorded in the CPRD in the UK

DRUG

Paliperidone

Paliperidone prescribed as recorded in the CPRD in the UK

DRUG

Lurasidone

Lurasidone prescribed as recorded in the CPRD in the UK

DRUG

Clozapine

Clozapine prescribed as recorded in the CPRD in the UK

DRUG

Amisulpride

Amisulpride prescribed as recorded in the CPRD in the UK

DRUG

Sertindole

Sertindole prescribed as recorded in the CPRD in the UK

DRUG

Zotepine

Zotepine prescribed as recorded in the CPRD in the UK

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01498770 - An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) | Biotech Hunter | Biotech Hunter